Prof. Dr. Henning Wackerhage, head of the Exercise Biology Research Group at the Technical University of Munich, was interviewed by Welt am Sonntag in June 2025 about current research on the amino acid taurine.
The conversation focused on the potential influence of taurine on age-related changes in organs and biological processes in humans. Prof. Wackerhage explained the background and objectives of the ongoing TauAge study – the world's first placebo-controlled human studies on the effects of taurine on biological aging.
The study, which is being conducted in cooperation with nutritional medicine specialist Prof. Hans Hauner, has so far enrolled 91 healthy volunteers between the ages of 55 and 75. All will receive either four grams of taurine daily or a placebo for six months. The goal is to investigate possible effects on biological aging. In addition to classic health parameters such as body weight, muscle strength, endurance, blood sugar, and blood lipid levels, blood proteins and epigenetic modifications of DNA will also be examined.
Detailed information about the interview appeared in the June 15, 2025, issue of Welt am Sonntag under the title “Es geht nicht ums ewige Leben.”